Inhibited or abnormal growth: While BPC-157 may promote local repair, it could theoretically promote unwanted cell proliferation in hormone-responsive tissues, affecting ovarian or endometrial function
The analysts used the following sources for the creation and completion of this valuable report: In-depth interviews of the major players in the market Detailed secondary research from competitors financial statements and published data Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years
Is the outcome a hormone surrogate (GH, IGF-1) or a clinical/imaging endpoint (visceral fat, liver fat)
ZabockaAJanuszM
Participants will be randomized 1:1 with block urns to balance age, NIHSS, ASPECTS and thrombolytic use to a 48-h infusion of 1 mL/kg/h RNS60 or placebo starting before arterial access closure and followed for 90 days
